This inventor holds 1 USPTO granted patent. Top assignees: Campus Science Support Facilities Gmbh, Imba-Institut Fur Molekulare Biotechnologie Gmbh. Active years: 2024.
Company Filing History:
1 out of 1 
1 out of 11 Years Active: 2024
Title: Monika Borowska: Innovator in CRISPR Technology
Introduction
Monika Borowska is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of molecular biotechnology, particularly in the development of CRISPR technology. Her innovative work has led to the creation of a patent that enhances the conditional expression of guide RNA in CRISPR systems.
Latest Patents
Monika holds a patent for "Conditional CRISPR sgRNA expression." This invention involves an expression cassette designed for the conditional expression of a single guide RNA (sgRNA) within a CRISPR/Cas9 system. The cassette includes a promoter, an sgRNA sequence, and a sequence flanked by at least a pair of recombinase recognition sites. The recombinase-activated recombination at these sites can excise the flanked sequence, allowing for precise control over sgRNA expression. This innovation has the potential to advance gene editing techniques significantly.
Career Highlights
Throughout her career, Monika has worked with notable organizations, including the Institute of Molecular Biotechnology (IMBA) and Campus Science Support Facilities GmbH. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Monika has collaborated with esteemed colleagues such as Ulrich Elling and Krzysztof Chylinski. These partnerships have fostered an environment of innovation and have led to advancements in CRISPR technology.
Conclusion
Monika Borowska's contributions to the field of biotechnology, particularly through her patent on conditional CRISPR sgRNA expression, highlight her role as a leading innovator. Her work continues to influence the landscape of genetic research and applications.